Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean

Gilead Sciences reached an agreement with the Pan American Health Organization to expand access to its HIV prevention drug across Latin America and the Caribbean. The partnership supports regional efforts to reduce new HIV infections, though no financial terms or expected sales impact were disclosed.